Pozen to acquire Tribute Pharmaceuticals

Pozen Inc. (Nasdaq: POZN) will acquire Tribute Pharmaceuticals in a deal valued at approximately $146 million. After completing the acquisition, Pozen will relocate its headquarters to Ireland. The stock price climbed $1.43 to close at $8.98.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.